BreachRx, a San Francisco-based cybersecurity firm, has raised $15m in Series A funding to scale its intelligent incident response platform for enterprise organisations.
The oversubscribed round was led by Ballistic Ventures, with participation from SYN Ventures, Overline, and Silver Buckshot Ventures. The funding also sees Ballistic Ventures general partner and former Mandiant CEO Kevin Mandia join the board, while journalist and author Nicole Perlroth becomes a board observer.
BreachRx offers a secure platform that automates cyber incident response across teams. Its technology delivers real-time coordination, dynamic playbooks, and clear tasking to ensure every stakeholder is aligned during a crisis. The tool supports communication, compliance, and resilience during cyberattacks.
The fresh capital will be used to expand BreachRx’s engineering and go-to-market teams as the company accelerates adoption and innovation. The firm already supports more than 100 clients, including Fortune 500 companies across financial services, healthcare, and critical infrastructure.
BreachRx CEO and co-founder Andy Lunsford said, “From founding the company that the Fortune 500 have on speed-dial when they have a breach to expertly leading his own company through one of the most high-profile breaches in history, Kevin knows better than anyone the importance of transparency, speed and precision in the response process.
“His experience and knowledge of how organizations should prepare for and operate cross-functionally in response to cyber events, coupled with Nicole’s perspective from reporting on major cyberattacks, are invaluable as we execute our next phase of growth.”
For more, visit RegTech Analyst
Keep up with all the latest FinTech news here
Copyright © 2025 FinTech Global
Investors
The following investor(s) were tagged in this article.
